Dechra Pharm PLC DPH Holding(s) in Company

  Dechra Pharm PLC (DPH) - Holding(s) in Company

RNS Number : 2099E
Dechra Pharmaceuticals PLC
28 May 2012






TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES^i
1. Identity of the issuer or the underlying issuer  Dechra Pharmaceuticals Plc
of existing shares to which voting rights are
attached:  ^ii                                                  
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights                            ü
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the              Schroders plc
notification obligation:  ^iii
4. Full name of shareholder(s)
(if different from 3.):^iv
5. Date of the transaction and date on
which the threshold is crossed or                        24.05.12
reached: ^v
6. Date on which issuer notified:                        25.05.12
7. Threshold(s) that is/are crossed or                  11% - 13%
reached: ^vi, vii



8. Notified details:
A: Voting rights attached to shares ^viii, ix
Class/type of Situation previous        Resulting situation after the triggering
shares        to the triggering         transaction
              transaction
if possible   Number        Number      Number     Number of voting  % of voting
using         of            of          of shares  rights            rights ^x
the ISIN CODE Shares        Voting      Direct     Direct Indirect   Direct   Indirect
                            Rights                 ^xi    ^xii
  Ordinary
GB0009633180

                13,630,410   9,981,410 16,370,249    N/A 12,082,549      N/A  13.913%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial   Expiration     Exercise/           Number of voting    % of voting
instrument          date ^xiii     Conversion Period   rights that may be  rights
                                   ^xiv                acquired if the
                                                       instrument is
                                                       exercised/
                                                       converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments ^xv, xvi
Resulting situation after the triggering transaction
Type of        Exercise     Expiration Exercise/   Number of voting     % of voting
financial      price        date ^xvii Conversion  rights instrument    rights ^xix,
instrument                             period      refers to            xx
                                       ^xviii
                                                                       
                                                                       Nominal Delta

                                                   
Total (A+B+C)
Number of voting rights                       Percentage of voting rights
12,082,549                                    13.913%



9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: ^xxi
Schroder              Investment              Management              Limited 
11,473,070 13.211%

Schroder Investment Management North America Limited 609,479
0.702%


Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information: The shares referred to in section 9 are held in
                            portfolios managed by those firms on a
                            discretionary basis for clients under investment
                            management agreements.
                                                    
14. Contact name:
                                               Liz Friedman
15. Contact telephone                               
number:
                                              020 7658 6000



                     This information is provided by RNS
           The company news service from the London Stock Exchange

END


HOLDMGZKNRRGZZG -0- May/28/2012 07:52 GMT